CA2429708A1 - Nucleic acid adjuvants - Google Patents

Nucleic acid adjuvants Download PDF

Info

Publication number
CA2429708A1
CA2429708A1 CA002429708A CA2429708A CA2429708A1 CA 2429708 A1 CA2429708 A1 CA 2429708A1 CA 002429708 A CA002429708 A CA 002429708A CA 2429708 A CA2429708 A CA 2429708A CA 2429708 A1 CA2429708 A1 CA 2429708A1
Authority
CA
Canada
Prior art keywords
composition
nucleic acid
subunit
antigen
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002429708A
Other languages
English (en)
French (fr)
Inventor
Joel R. Haynes
Joshua E. Arrington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2429708A1 publication Critical patent/CA2429708A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002429708A 2000-11-27 2001-11-26 Nucleic acid adjuvants Abandoned CA2429708A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72431500A 2000-11-27 2000-11-27
US09/724,315 2000-11-27
PCT/US2001/043151 WO2003004055A2 (en) 2000-11-27 2001-11-26 Nucleic acid adjuvants

Publications (1)

Publication Number Publication Date
CA2429708A1 true CA2429708A1 (en) 2003-01-16

Family

ID=24909936

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002429708A Abandoned CA2429708A1 (en) 2000-11-27 2001-11-26 Nucleic acid adjuvants

Country Status (16)

Country Link
EP (1) EP1379273B1 (enExample)
JP (1) JP4221289B2 (enExample)
KR (1) KR20040045391A (enExample)
CN (1) CN1317034C (enExample)
AT (1) ATE442858T1 (enExample)
AU (1) AU2001297988B2 (enExample)
BR (1) BR0115646A (enExample)
CA (1) CA2429708A1 (enExample)
DE (1) DE60139959D1 (enExample)
DK (1) DK1379273T3 (enExample)
ES (1) ES2332261T3 (enExample)
IL (2) IL156041A0 (enExample)
MX (1) MXPA03004638A (enExample)
NZ (1) NZ526175A (enExample)
PT (1) PT1379273E (enExample)
WO (1) WO2003004055A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101225395B1 (ko) 2003-10-10 2013-01-28 파우더젝트 백신, 인코포레이티드 핵산 구조물
BRPI0507579A (pt) 2004-02-11 2007-07-03 Angeletti P Ist Richerche Bio molécula de ácido nucleico, vetor, célula hospedeira, processo para expressar uma proteìna de fusão cea em uma célula hospedeira recombinante, proteìna de fusão cea purificada, método de prevenção ou tratamento de cáncer, plasmìdeo de vacina, e, método de tratamento de um mamìfero sofrendo de ou predisposto a um cáncer associados com cea
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
US8389686B2 (en) 2008-05-07 2013-03-05 Osaka University Noncovalent collagen crosslinking agent
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
CA2848656C (en) 2010-09-15 2017-10-10 Randall J. Mrsny Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
CN103060253A (zh) * 2013-01-24 2013-04-24 麻丽丹 霍乱弧菌ctxAB基因的质粒克隆菌株以及制备方法和应用
DK3139965T3 (da) 2014-05-07 2021-11-22 Applied Molecular Transport Inc Fusionsmolekyler afledt af cholix-toksin til oral indgivelse af biologisk aktive stoffer
EP4082558B1 (en) 2018-03-08 2023-08-23 Applied Molecular Transport Inc. Toxin-derived delivery constructs for oral delivery
KR20210110294A (ko) 2018-11-07 2021-09-07 어플라이드 몰레큘라 트랜스포트 인크. 통과세포외배출용 전달 구조체 및 관련 방법
BR112022002962A2 (pt) 2019-08-16 2022-07-05 Applied Molecular Transport Inc Composições, formulações e produção e purificação de interleucina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
GB9416663D0 (en) 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
AU3703895A (en) 1994-10-24 1996-05-15 Oxford Biosciences Limited Particle delivery
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
US6056960A (en) * 1995-06-07 2000-05-02 Kaslow; Harvey R. Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization

Also Published As

Publication number Publication date
KR20040045391A (ko) 2004-06-01
EP1379273B1 (en) 2009-09-16
DE60139959D1 (de) 2009-10-29
CN1537013A (zh) 2004-10-13
BR0115646A (pt) 2005-12-13
MXPA03004638A (es) 2004-04-20
ES2332261T3 (es) 2010-02-01
WO2003004055A3 (en) 2003-11-20
JP2004536107A (ja) 2004-12-02
CN1317034C (zh) 2007-05-23
IL156041A0 (en) 2003-12-23
ATE442858T1 (de) 2009-10-15
JP4221289B2 (ja) 2009-02-12
AU2001297988B2 (en) 2006-10-26
PT1379273E (pt) 2009-11-27
EP1379273A2 (en) 2004-01-14
NZ526175A (en) 2006-01-27
IL156041A (en) 2010-05-17
WO2003004055A2 (en) 2003-01-16
DK1379273T3 (da) 2009-11-09

Similar Documents

Publication Publication Date Title
KR101891195B1 (ko) 공통 항원 구성체 및 이것으로부터 만들어진 백신 및 말라리아를 치료하기 위한 이것의 사용방법
AU2017338846B2 (en) Co-stimulatory domains for use in genetically-modified cells
RU2186109C2 (ru) Полинуклеотидная противотуберкулезная вакцина
AU2004279991B2 (en) Nucleic acid constructs
KR102382942B1 (ko) B형 간염 바이러스 코어 단백질 및 표면 항원 단백질 및 이를 포함하는 백신
EA033467B1 (ru) Молекула нуклеиновой кислоты для индукции иммунного ответа против герпесвируса и ее применение
CA2429708A1 (en) Nucleic acid adjuvants
KR20250136930A (ko) 사람 파필로마바이러스 백신 및 이의 용도
KR20060123138A (ko) 방법
KR20230087583A (ko) 항원을 mhc-ii 경로로 전달하고 숙주에서 cd4+ 및 cd8+ t-세포 반응을 유도하는 새로운 세대의 렌티바이러스 벡터
US6344202B1 (en) DNA immunization against chlaymdia infection
CA2393861A1 (en) Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
DK2844759T3 (en) Vaccination by recombinant yeast by eliciting a protective humoral immune response against defined antigens
AU2001297988A1 (en) Nucleic acid adjuvants
US20030162733A1 (en) Nucleic acid adjuvants
KR20200128703A (ko) B형 간염 백신 및 이의 용도
US20050266024A1 (en) Adjuvant
Tähtinen et al. DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector
KR100592825B1 (ko) 면역원성 리포좀 조성물
Paterson Rational approaches to immune regulation
EP1007687A1 (en) Fiv vaccine

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20121126